---
document_datetime: 2023-09-21 20:28:36
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/trulicity-epar-all-authorised-presentations_en.pdf
document_name: trulicity-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.926505
conversion_datetime: 2025-12-20 18:04:33.237755
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging               | Content (concentration)   | Pack size                               |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------------------|---------------------------|-----------------------------------------|
| EU/1/14/956/001  | Trulicity         | 0.75 mg    | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (1.5 mg/ml)        | 2 pre-filled pens                       |
| EU/1/14/956/002  | Trulicity         | 0.75 mg    | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (1.5 mg/ml)        | 4 pre-filled pens                       |
| EU/1/14/956/003  | Trulicity         | 0.75 mg    | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (1.5 mg/ml)        | 12 (3 x 4) pre- filled pens (multipack) |
| EU/1/14/956/006  | Trulicity         | 1.5 mg     | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (3 mg/ml)          | 2 pre-filled pens                       |
| EU/1/14/956/007  | Trulicity         | 1.5 mg     | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (3 mg/ml)          | 4 pre-filled pens                       |
| EU/1/14/956/008  | Trulicity         | 1.5 mg     | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (3 mg/ml)          | 12 (3 x 4) pre- filled pens (multipack) |
| EU/1/14/956/011  | Trulicity         | 3 mg       | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (6 mg/ml)          | 2 pre-filled pens                       |
| EU/1/14/956/012  | Trulicity         | 3 mg       | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (6 mg/ml)          | 4 pre-filled pens                       |
| EU/1/14/956/013  | Trulicity         | 3 mg       | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (6 mg/ml)          | 12 (3 x 4) pre- filled pens (multipack) |
| EU/1/14/956/014  | Trulicity         | 4.5 mg     | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (9 mg/ml)          | 2 pre-filled pens                       |
| EU/1/14/956/015  | Trulicity         | 4.5 mg     | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (9 mg/ml)          | 4 pre-filled pens                       |

<div style=\"page-break-after: always\"></div>

| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging               | Content (concentration)   | Pack size                               |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------------------|---------------------------|-----------------------------------------|
| EU/1/14/956/016  | Trulicity         | 4.5 mg     | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.5 ml (9 mg/ml)          | 12 (3 x 4) pre- filled pens (multipack) |